DURING 2017 THE COMPANY EXPERIENCED A MOMENT OF EXPANSION IN RELATION TO THE SETTING UP OF ITS OWN PRODUCTION UNIT THAT ALLOWS IT TO MOVE FROM INNOVATIVE START-UP FOCUSED EXCLUSIVELY ON RESEARCH AND DEVELOPMENT, MAINLY DIAGNOSTIC KITS, TO A REAL PRODUCTION COMPANY. THE FIRST KIT PUT INTO PRODUCTION WILL BE THE ONE FOR PAPILLOMA VIRUS; THE KIT HAS INNOVATIVE CHARACTERISTICS IN THE SAMPLING MODE, IN THE TIME AND COST OF ANALYSIS. IN ADDITION TO